Literature DB >> 22340431

Management of acute coronary syndrome: achievements and goals still to pursue. Novel developments in diagnosis and treatment.

H Boden1, B L van der Hoeven, I Karalis, M J Schalij, J W Jukema.   

Abstract

Acute coronary syndromes contribute a substantial part of the global disease burden. To realize a reduction in mortality and morbidity, the management of patients with these conditions involves the integration of several different approaches. Timely delivery of appropriate care is a key factor, as the beneficial effect of reperfusion is greatest when performed as soon as possible. Innovations in antithrombotic therapy have also contributed significantly to improvements in the prevention of ischaemic complications. However, with the use of such treatment, an increase in the risk of bleeding is inevitable. Therefore, the greatest challenge is now to obtain an optimal balance between the prevention of ischaemic complications and the risk of bleeding. In this regard, identification of patients at highest risk of either one is essential.
© 2012 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22340431     DOI: 10.1111/j.1365-2796.2012.02533.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  5 in total

1.  Projected inhibition of platelet aggregation with ticagrelor twice daily vs. clopidogrel once daily based on patient adherence data (the TWICE project).

Authors:  Bernard Vrijens; Marc J Claeys; Victor Legrand; Eef Vandendriessche; Frans Van de Werf
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

2.  Use of CHADS₂ and CHA₂DS₂-VASc scores to predict subsequent myocardial infarction, stroke, and death in patients with acute coronary syndrome: data from Taiwan acute coronary syndrome full spectrum registry.

Authors:  Su-Kiat Chua; Huey-Ming Lo; Chiung-Zuan Chiu; Kou-Gi Shyu
Journal:  PLoS One       Date:  2014-10-24       Impact factor: 3.240

3.  Trends in evidence-based treatment and mortality for ST elevation myocardial infarction in Malaysia from 2006 to 2013: time for real change.

Authors:  Padmaa Venkatason; Yong Z Zubairi; Imran Hafidz; Wan Azman Wan; Ahmad S Zuhdi
Journal:  Ann Saudi Med       Date:  2016 May-Jun       Impact factor: 1.526

4.  Prehospital and in-hospital use of healthcare resources in patients surviving acute coronary syndromes: an analysis of the EPICOR registry.

Authors:  Lieven Annemans; Nicolas Danchin; Frans Van de Werf; Stuart Pocock; Muriel Licour; Jesús Medina; Héctor Bueno
Journal:  Open Heart       Date:  2016-02-24

5.  The contribution of gender and age on early and late mortality following ST-segment elevation myocardial infarction: results from the Korean Acute Myocardial Infarction National Registry with Registries.

Authors:  Ae-Young Her; Eun-Seok Shin; Yong Hoon Kim; Scot Garg; Myung Ho Jeong
Journal:  J Geriatr Cardiol       Date:  2018-03       Impact factor: 3.327

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.